abacavir 600 MG / lamivudine 300 MG Oral Tablet

RxCUI
602393
RxNorm name
abacavir 600 MG / lamivudine 300 MG Oral Tablet
Display name
abacavir 600 MG / lamivudine 300 MG Oral Tablet
Full name
abacavir 600 MG / lamivudine 300 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Abacavir and LamivudineABACAVIR AND LAMIVUDINELaurus Labs Limitedd12e80eb-906c-4932-bb03-b4060ba1d31c2026-01-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 602393
ABACAVIR and LAMIVUDINEABACAVIR AND LAMIVUDINECamber Pharmaceuticals, Inc.e8988924-c18c-4e91-ab79-2d84e72bfa0d2025-05-31Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 602393
Abacavir and LamivudineABACAVIR AND LAMIVUDINEMacleods Pharmaceuticals Limitedd36624c8-d773-4f99-81fc-433fae17feb32025-03-03Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 602393
Abacavir and LamivudineABACAVIR AND LAMIVUDINEAurobindo Pharma Limiteddeda1a24-2f51-4601-9881-347f472709402024-05-19Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 602393
Abacavir and LamivudineABACAVIR AND LAMIVUDINELupin Pharmaceuticals, Inc.1d8e7bb9-8624-4739-9719-fe25109d63652023-10-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 602393
Abacavir and LamivudineABACAVIR AND LAMIVUDINECipla USA Inc.c0488bee-2f18-4e2e-8e11-68543c023dec2022-01-18Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 602393

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
1d8e7bb9-8624-4739-9719-fe25109d6365abacavir 600 MG / lamivudine 300 MG Oral TabletSCD14These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 200420231030
1d8e7bb9-8624-4739-9719-fe25109d6365abacavir (as abacavir sulfate) 600 MG / lamivudine 300 MG Oral TabletSY14These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 200420231030
1d8e7bb9-8624-4739-9719-fe25109d6365abacavir sulfate 600 MG / lamiVUDine 300 MG Oral TabletPSN14These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 200420231030
1d8e7bb9-8624-4739-9719-fe25109d6365abacavir 600 MG / 3TC 300 MG Oral TabletSY14These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 200420231030
c0488bee-2f18-4e2e-8e11-68543c023decabacavir sulfate 600 MG / lamiVUDine 300 MG Oral TabletPSN8These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS ABACAVIR and LAMIVUIDNE Tablets, for oral use Initial U.S. Approval:200420220118
c0488bee-2f18-4e2e-8e11-68543c023decabacavir 600 MG / 3TC 300 MG Oral TabletSY8These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS ABACAVIR and LAMIVUIDNE Tablets, for oral use Initial U.S. Approval:200420220118
c0488bee-2f18-4e2e-8e11-68543c023decabacavir (as abacavir sulfate) 600 MG / lamivudine 300 MG Oral TabletSY8These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS ABACAVIR and LAMIVUIDNE Tablets, for oral use Initial U.S. Approval:200420220118
c0488bee-2f18-4e2e-8e11-68543c023decabacavir 600 MG / lamivudine 300 MG Oral TabletSCD8These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS ABACAVIR and LAMIVUIDNE Tablets, for oral use Initial U.S. Approval:200420220118
deda1a24-2f51-4601-9881-347f47270940abacavir 600 MG / 3TC 300 MG Oral TabletSY7These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 200420240519
deda1a24-2f51-4601-9881-347f47270940abacavir sulfate 600 MG / lamiVUDine 300 MG Oral TabletPSN7These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 200420240519
deda1a24-2f51-4601-9881-347f47270940abacavir 600 MG / lamivudine 300 MG Oral TabletSCD7These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 200420240519
deda1a24-2f51-4601-9881-347f47270940abacavir (as abacavir sulfate) 600 MG / lamivudine 300 MG Oral TabletSY7These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 200420240519
d12e80eb-906c-4932-bb03-b4060ba1d31cabacavir (as abacavir sulfate) 600 MG / lamivudine 300 MG Oral TabletSY4These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 200420260112
d12e80eb-906c-4932-bb03-b4060ba1d31cabacavir 600 MG / lamivudine 300 MG Oral TabletSCD4These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 200420260112
d12e80eb-906c-4932-bb03-b4060ba1d31cabacavir sulfate 600 MG / lamiVUDine 300 MG Oral TabletPSN4These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 200420260112
d12e80eb-906c-4932-bb03-b4060ba1d31cabacavir 600 MG / 3TC 300 MG Oral TabletSY4These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 200420260112
d36624c8-d773-4f99-81fc-433fae17feb3abacavir 600 MG / 3TC 300 MG Oral TabletSY2These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR AND LAMIVUDINE TABLETS, for oral use Initial U.S. Approval: 200420250303
d36624c8-d773-4f99-81fc-433fae17feb3abacavir 600 MG / lamivudine 300 MG Oral TabletSCD2These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR AND LAMIVUDINE TABLETS, for oral use Initial U.S. Approval: 200420250303
d36624c8-d773-4f99-81fc-433fae17feb3abacavir (as abacavir sulfate) 600 MG / lamivudine 300 MG Oral TabletSY2These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR AND LAMIVUDINE TABLETS, for oral use Initial U.S. Approval: 200420250303
d36624c8-d773-4f99-81fc-433fae17feb3abacavir sulfate 600 MG / lamiVUDine 300 MG Oral TabletPSN2These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR AND LAMIVUDINE TABLETS, for oral use Initial U.S. Approval: 200420250303
e0fc8605-1d64-41ab-af7e-bcf66a57c1fdabacavir 600 MG / 3TC 300 MG Oral TabletSY2EPZICOM ® (abacavir sulfate and lamivudine) Tablets20100511
e0fc8605-1d64-41ab-af7e-bcf66a57c1fdabacavir (as abacavir sulfate) 600 MG / lamivudine 300 MG Oral TabletSY2EPZICOM ® (abacavir sulfate and lamivudine) Tablets20100511
e0fc8605-1d64-41ab-af7e-bcf66a57c1fdabacavir sulfate 600 MG / lamiVUDine 300 MG Oral TabletPSN2EPZICOM ® (abacavir sulfate and lamivudine) Tablets20100511
e0fc8605-1d64-41ab-af7e-bcf66a57c1fdabacavir 600 MG / lamivudine 300 MG Oral TabletSCD2EPZICOM ® (abacavir sulfate and lamivudine) Tablets20100511
e8988924-c18c-4e91-ab79-2d84e72bfa0dabacavir 600 MG / lamivudine 300 MG Oral TabletSCD1These highlights do not include all the information needed to use ABACAVIR and LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR and LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 200420250531
e8988924-c18c-4e91-ab79-2d84e72bfa0dabacavir (as abacavir sulfate) 600 MG / lamivudine 300 MG Oral TabletSY1These highlights do not include all the information needed to use ABACAVIR and LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR and LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 200420250531
e8988924-c18c-4e91-ab79-2d84e72bfa0dabacavir 600 MG / 3TC 300 MG Oral TabletSY1These highlights do not include all the information needed to use ABACAVIR and LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR and LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 200420250531
e8988924-c18c-4e91-ab79-2d84e72bfa0dabacavir sulfate 600 MG / lamiVUDine 300 MG Oral TabletPSN1These highlights do not include all the information needed to use ABACAVIR and LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR and LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 200420250531
080e3423-5962-4465-8e78-cd8793699336abacavir (as abacavir sulfate) 600 MG / lamivudine 300 MG Oral TabletSY1EPZICOM ® (abacavir sulfate and lamivudine) Tablets20100701
080e3423-5962-4465-8e78-cd8793699336abacavir 600 MG / 3TC 300 MG Oral TabletSY1EPZICOM ® (abacavir sulfate and lamivudine) Tablets20100701
080e3423-5962-4465-8e78-cd8793699336abacavir sulfate 600 MG / lamiVUDine 300 MG Oral TabletPSN1EPZICOM ® (abacavir sulfate and lamivudine) Tablets20100701
080e3423-5962-4465-8e78-cd8793699336abacavir 600 MG / lamivudine 300 MG Oral TabletSCD1EPZICOM ® (abacavir sulfate and lamivudine) Tablets20100701